Related Experiment Videos

[Infections after bone marrow transplantation in childhood]

S Ludwig1, U Ludwig, I Färber

  • 1Universitäts-Kinderklinik Jussuf Ibrahim, Jena.

Kinderarztliche Praxis
|June 1, 1992
PubMed

Insights

This retrospective study of 66 children after bone marrow transplantation found bacterial infections common early on, with gram-positive bacteria dominating. Cytomegalovirus infections posed the most significant risk, highlighting the need for monitoring drug levels.

Area of Science:

  • Pediatric Hematology Oncology
  • Infectious Diseases
  • Transplantation Immunology

Context:

  • Bone marrow transplantation (BMT) is a critical treatment for pediatric hematologic malignancies and other conditions.
  • Post-BMT patients are highly susceptible to infections due to immunosuppression.
  • Understanding infection patterns is crucial for improving outcomes in pediatric BMT.

Purpose:

  • To retrospectively analyze the incidence and types of infections in children following bone marrow transplantation.
  • To identify the most common bacterial, viral, and fungal pathogens encountered post-BMT.
  • To assess the impact of specific infections on patient prognosis and complications.

Summary:

  • Bacterial infections were most prevalent in the early post-transplant period before marrow engraftment.
  • Gram-positive bacteria, particularly coagulase-negative staphylococci, dominated positive blood cultures.
  • Cytomegalovirus (CMV) infections were significant due to high incidence and association with CMV-associated interstitial pneumonia (IP).
  • Fungal infections, notably systemic aspergillosis, represented a major complication.
  • Herpes simplex virus (HSV), varicella zoster virus (VZV), and Epstein Barr virus (EBV) infections did not significantly affect prognosis.

Impact:

  • Findings underscore the importance of vigilant monitoring for bacterial and viral infections in the early post-BMT phase.
  • Highlights Cytomegalovirus (CMV) as a critical pathogen requiring specific attention and management strategies.
  • Suggests that therapeutic drug monitoring of antibiotic and antifungal serum levels can enhance treatment efficacy and safety.

Related Concept Videos